schizophrenia

Study identifies cognitive benefits of ketamine in patients with treatment-resistant depression

by

Ket­a­mine mol­e­cules attach them­selves to NMDA neu­ronal recep­tors, which play an impor­tant role in brain plas­tic­i­ty and pre­dic­tive pro­cess­ing. C22H31NO2, CC BY-SA

Which fac­tors deter­mine what we believe about our world, our­selves, our past, and our future? Cog­ni­tive neu­ro­science sug­gests that our beliefs are depen­dent on brain activ­i­ty, specif­i­cal­ly on the way our brains process sen­so­ry infor­ma­tion in order to make sense of our environment.

These beliefs (defined as prob­a­bil­i­ty esti­mates) are cen­tral to our brain’s pre­dic­tive pro­cess­ing func­tion, which enables it to pre­dict the prob­a­bilis­tic struc­ture of the world around us. These pre­dic­tions could even be the fun­da­men­tal build­ing blocks of men­tal states, such as per­cep­tions and emotions.

Many psy­chi­atric dis­or­ders, such as depres­sion and schiz­o­phre­nia, are char­ac­terised by irreg­u­lar beliefs whose ori­gins we still don’t ful­ly under­stand. But if we can iden­ti­fy the cere­bral sys­tems gov­ern­ing them, we could tar­get those very areas in a bid to alle­vi­ate the pain asso­ci­at­ed to these ill­ness­es. [Read more…] about Study iden­ti­fies cog­ni­tive ben­e­fits of ket­a­mine in patients with treat­ment-resis­tant depression

Otsuka and Virtual Reality start-up Jolly Good sign $43M deal to promote Social Skills Training (SST) therapies, helping schizophrenia patients first

by

Jol­ly Good and Tei­jin Phar­ma Form a Part­ner­ship to Devel­op VR Dig­i­tal Ther­a­peu­tics for Depression

Otsu­ka signs on Jol­ly Good for $43M men­tal health VR deal (Fierce Biotech):

The duo will build out software—hosted on Jol­ly Good’s VR gog­gles and con­nect­ed tablet devices, and backed by Otsuka’s exper­tise in devel­op­ing neu­ro­log­i­cal therapeutics—that takes a social skills train­ing (SST) approach to treat­ing men­tal ill­ness. SST is a behav­ioral ther­a­py in which patients with anx­i­ety, mood and per­son­al­i­ty dis­or­ders, among oth­er con­di­tions, are taught on a step-by-step basis how to nav­i­gate spe­cif­ic social inter­ac­tions. [Read more…] about Otsu­ka and Vir­tu­al Real­i­ty start-up Jol­ly Good sign $43M deal to pro­mote Social Skills Train­ing (SST) ther­a­pies, help­ing schiz­o­phre­nia patients first

Debunking four myths about decision-making capacity to keep Britney Spears and others safe

by

Brit­ney Spears’ impas­sioned remarks in court have raised many ques­tions about con­ser­va­tor­ships, includ­ing when they’re nec­es­sary and whether they effec­tive­ly pro­tect someone’s best interests.

When one los­es the capac­i­ty to make deci­sions for one­self the court appoints a guardian, or con­ser­va­tor, to make those deci­sions. Appoint­ing some­one to make deci­sions about per­son­al and finan­cial mat­ters on another’s behalf has been part of civ­il soci­ety since the ancient Greeks. Today, all juris­dic­tions in the U.S. have con­ser­va­tor­ship laws to pro­tect peo­ple who lack the abil­i­ty to make their own deci­sions. [Read more…] about Debunk­ing four myths about deci­sion-mak­ing capac­i­ty to keep Brit­ney Spears and oth­ers safe

Update: A life of cognitive and physical exercise helps you stay sharp in your 70s and beyond

by

Wel­come to a new edi­tion of Sharp­Brains’ e‑newsletter, fea­tur­ing 13 fas­ci­nat­ing brain research find­ings, use­ful resources–and a brain teas­er to test your atten­tion skills.

#1. Good news of the month: Elders today are in sig­nif­i­cant­ly bet­ter shape–physically and cognitively–than three decades ago

#2. A dis­tinc­tion WITH a dif­fer­ence: Actu­al, sus­tained practice–not mere knowledge–is need­ed to har­ness neu­ro­plas­tic­i­ty and improve cog­ni­tion over time

#3. “Be mind­ful that with the rapid changes we are expe­ri­enc­ing, our brains are going through accel­er­at­ed learn­ing. Our brains get tired just as our bod­ies would if we ran a marathon with­out train­ing.” How COVID-relat­ed stress can dis­rupt your brain cir­cuits and nine tips to pre­vent it

#4. Yes, Yes, and Yes. To har­ness our best selves, “Tem­per your empa­thy, train your com­pas­sion, and avoid the news”

#5. Things start ear­ly. Marsh­mal­low Test with a twist: 3- and 4‑year-olds kids dis­play more self-con­trol when their rep­u­ta­tion is at stake

#6. Which is why we look for­ward to see­ing 9,000+ stu­dents, plus their many teach­ers and admin­is­tra­tors, fur­ther devel­op their unique brains and minds in years ahead: Help­ing shape the future of life­long learn­ing via SEK Edu­ca­tion Group

#7. “… it would cer­tain­ly be pre­ma­ture to sug­gest that mov­ing to a high alti­tude state would improve a child’s ADHD symp­toms. How­ev­er, the find­ings high­light the val­ue of keep­ing an open mind in efforts to under­stand the devel­op­ment of ADHD and the role nat­ur­al envi­ron­ments may play in poten­tial­ly alle­vi­at­ing it.” Study finds sur­pris­ing cor­re­la­tion between states’ ele­va­tion and ADHD prevalence

#9. Time to start pay­ing seri­ous atten­tion to the brain/ cog­ni­tive side effects of com­mon med­ica­tions. Anti­cholin­er­gic drugs found to sig­nif­i­cant­ly increase risk of cog­ni­tive decline, espe­cial­ly among those with Alzheimer’s Dis­ease bio­mark­ers or genet­ic predisposition

#10. Fas­ci­nat­ing: “After a 14-day train­ing peri­od … visu­ospa­tial skills improved by 40%. This increase in visu­ospa­tial abil­i­ty was shown to be direct­ly respon­si­ble for a reduc­tion in motion sick­ness by 51% in the sim­u­la­tor … and a 58% reduc­tion in the on-road tri­al.” Study: Self-dri­ving cars will increase motion sickness…unless we retrain our brains to improve visu­ospa­tial skills

#11. Behav­ioral health and neu­ro­plas­tic­i­ty meet big phar­ma to hope­ful­ly address a huge need. Click Ther­a­peu­tics and Boehringer Ingel­heim part­ner to devel­op and mar­ket a dig­i­tal ther­a­peu­tic to treat schizophrenia

#12. Neu­ralink: Thumbs up or down?

#13. Brain teas­er: Did you notice the numer­i­cal error as it hap­pened? If not, feel free to go back and find it now 🙂

 

Wish­ing you a safe and healthy October,

 

Alvaro Fer­nan­dez and the Sharp­Brains Team

Click Therapeutics and Boehringer Ingelheim partner to develop and market a digital therapeutic to treat schizophrenia

by

Boehringer Ingel­heim, Click Ther­a­peu­tics ink $500M+ dig­i­tal ther­a­peu­tics devel­op­ment, com­mer­cial­iza­tion deal (Mobi­Health­News):

Inter­na­tion­al phar­ma Boehringer Ingel­heim and pre­scrip­tion dig­i­tal ther­a­peu­tics com­pa­ny Click Ther­a­peu­tics have inked a $500 mil­lion-plus deal to joint­ly devel­op and com­mer­cial­ize a dig­i­tal treat­ment for patients with schiz­o­phre­nia. [Read more…] about Click Ther­a­peu­tics and Boehringer Ingel­heim part­ner to devel­op and mar­ket a dig­i­tal ther­a­peu­tic to treat schizophrenia

The way we approach Mental Health today is broken beyond repair. The question is, what comes next, and how fast can we get there?

by

The hid­den links between men­tal dis­or­ders (Nature):

In 2018, psy­chi­a­trist Oleguer Plana-Ripoll was wrestling with a puz­zling fact about men­tal dis­or­ders. He knew that many indi­vid­u­als have mul­ti­ple con­di­tions — anx­i­ety and depres­sion, say, or schiz­o­phre­nia and bipo­lar dis­or­der. He want­ed to know how com­mon it was to have more than one diag­no­sis, so he got his hands on a data­base con­tain­ing the med­ical details of around 5.9 mil­lion Dan­ish citizens.

He was tak­en aback by what he found. Every sin­gle men­tal dis­or­der pre­dis­posed the patient to every oth­er men­tal dis­or­der — no mat­ter how dis­tinct the symp­toms. “We knew that comor­bid­i­ty was impor­tant, but we didn’t expect to find asso­ci­a­tions for all pairs,” says Plana-Ripoll, who is based at Aarhus Uni­ver­si­ty in Denmark.

[Read more…] about The way we approach Men­tal Health today is bro­ken beyond repair. The ques­tion is, what comes next, and how fast can we get there?